{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/a4c5de36-8260-4222-8e38-ff997dc73436/6a112e92-2071-4876-b20f-d376bf43f92b?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Companies & Markets Show: Bye-buy (sell)","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61b9b44742e856e989985776/61b9b4cc24374a00129af483.jpg?height=200","description":"<p>On this week's Companies &amp; Markets Show editor John Hughman is joined by Harriet Russell, who's signing off after five and a half eventful years covering pharma and retail with a week of big stories from both sectors – including good news for GSK and Tesco, and predictably bad news for Indivior and Debenhams.</p>","author_name":"Investors' Chronicle"}